abacavir/dolutegravir/lamivudine
Jump to navigation
Jump to search
Indications
Adverse effects
- increase in serum creatinine due to inhibition of proximal tubule secretion of creatinine by dolutegravir, not due to decrease in glomerular filtration rate[2]
More general terms
Components
- abacavir (Ziagen, ABC)
- dolutegravir (Tivicay, DTG)
- lamivudine (3TC, Epivir)
- dolutegravir/lamivudine (Dovato)
References
- ↑ Walmsley SL et al Dolutegravir plus Abacavir-Lamivudine for the Treatment of HIV-1 Infection. N Engl J Med 2013; 369:1807-1818. November 7, 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24195548 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1215541
- ↑ 2.0 2.1 Medical Knowledge Self Assessment Program (MKSAP) 19. American College of Physicians, Philadelphia 2021